EVIO (EVIO) Stock Price, News & Analysis

Company Overview

EVIO Inc. was a cannabis testing company that provided analytical laboratory services to cannabis and hemp businesses. Its services were designed to help producers, processors and other industry participants evaluate product quality, safety and regulatory compliance.

The company’s testing capabilities included analysis of cannabinoid potency, terpenes, pesticides, residual solvents, heavy metals and microbiological contaminants. Its laboratories served markets in the United States and, historically, the company also pursued opportunities in Canada.

EVIO’s operations were focused on state-regulated cannabis markets, where independent laboratory testing is generally required before products can be sold to consumers. Publicly available information about the company’s current operations and leadership is limited, so no additional management or geographic details are included here.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 13.00 million shs
• Average Volume: 255,000 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:EVIO
• CIK: 715788
• Web: www.eviolabs.com
• Phone: (888) 544-3846
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A